New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 27, 2014
08:06 EDTRTRXRetrophin completes acquisition of Manchester Pharmaceuticals
Retrophin announced the completion of the previously announced acquisition of Manchester Pharmaceuticals LLC for a total of $62.5M, including an upfront payment of $29.5M, plus other payments based on product sales. Retrophin intends to pursue U.S. regulatory approval for Chenodal in cerebrotendinous xanthomatosis.
News For RTRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 18, 2014
07:46 EDTRTRXRetrophin management to meet with Deutsche Bank
Meeting to be held in Baltimore on December 18 hosted by Deutsche Bank.
December 16, 2014
08:02 EDTRTRXRetrophin announces addition to NASDAQ Biotechnology Index
Subscribe for More Information
December 11, 2014
07:22 EDTRTRXRetrophin management to meet with Deutsche Bank
Subscribe for More Information
December 10, 2014
07:25 EDTRTRXRetrophin management to meet with Deutsche Bank
Meeting to be held in New York on December 10 hosted by Deutsche Bank.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use